Article ID Journal Published Year Pages File Type
8790196 Urologic Oncology: Seminars and Original Investigations 2018 9 Pages PDF
Abstract
AXL expression was associated with worse clinical outcome and may be an important prognostic biomarker in sunitinib-treated patients with metastatic renal cell carcinoma.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Authors
, , , , , , , , , , , , , , ,